Implementation of patient dosimetry in the clinical practice after targeted radiotherapy using [177Lu-[DOTA0, Tyr3]-octreotate

by Lore Santoro, Erick Mora-Ramirez, Dorian Trauchessec, Soufiane Chouaf, Pierre Eustache, Jean-Pierre Pouget, Pierre-Olivier Kotzki, Manuel Bardiès, Emmanuel Deshayes
Published 2018-11-01

⁹⁹mTcO₄--, auger-mediated thyroid stunning: dosimetric requirements and associated molecular events.

by Béatrice Cambien, Philippe R Franken, Audrey Lamit, Thibault Mauxion, Peggy Richard-Fiardo, Julien Guglielmi, Lydie Crescence, Bernard Mari, Thierry Pourcher, Jacques Darcourt, Manuel Bardiès, Georges Vassaux
Published 2014-01-01

Setting up a quantitative SPECT imaging network for a European multi-centre dosimetry study of radioiodine treatment for thyroid cancer as part of the MEDIRAD project

by Jan Taprogge, Francesca Leek, Tino Schurrat, Johannes Tran-Gia, Delphine Vallot, Manuel Bardiès, Uta Eberlein, Michael Lassmann, Susanne Schlögl, Alex Vergara Gil, the MEDIRAD WP3 Investigator Team, Glenn D. Flux
Published 2020-10-01

Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig.

by Mehrdad Khoshnevis, Claude Carozzo, Richard Brown, Manuel Bardiès, Catherine Bonnefont-Rebeix, Sara Belluco, Christophe Nennig, Lionel Marcon, Olivier Tillement, Hélène Gehan, Cédric Louis, Ilyes Zahi, Thierry Buronfosse, Thierry Roger, Frédérique Ponce
Published 2020-01-01

Nonlinearity in MCF7 Cell Survival Following Exposure to Modulated 6 MV Radiation Fields

by Laetitia Lacoste-Collin MD, PhD, Marion Castiella MD, PhD, Xavier Franceries PhD, Emmanuelle Cassol PhD, Laure Vieillevigne PhD, Veronica Pereda PhD, Manuel Bardies PhD, Monique Courtade-Saïdi MD, PhD
Published 2015-10-01